Patents for C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120) |
---|
03/06/2003 | WO2002099097A8 Novel compounds for chemiluminescense procedures |
03/06/2003 | US20030045538 Viologen linked acridine based molecule and process for the preparation thereof |
03/05/2003 | CN1400974A Amino acid derivatives and use thereof as NEP, ACE and ECE inhibitors |
02/13/2003 | US20030032801 Phenothiazine or iminodibenzyl derivatives as antimalarial agents |
02/12/2003 | CN1397148A Luminescent element material and luminescent element comprising the same |
02/11/2003 | CA2030715C Hexahydro-1h-quino¬4,3,2-ef|¬1,4|benzoxazepines and related compounds, a process and intermediates for their preparation and their use as medicaments |
02/05/2003 | EP0934277B1 Process for the preparation of n- 2-(dimethylamino)ethyl]acridine-4-carboxamide |
02/05/2003 | CN1100759C Xanthene and arcridine derivative and its use |
02/04/2003 | US6514987 Useful for inactivating pathogens in a material, such as a blood product, and then degrades to breakdown products |
01/30/2003 | US20030023089 Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes |
01/29/2003 | EP1278747A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
01/28/2003 | US6512119 Bistable molecular mechanical devices with an appended rotor activated by an electric field for electronic switching, gating and memory applications |
01/16/2003 | WO2003004091A2 Aromatic sulfenates for type i phototherapy |
01/16/2003 | US20030013677 Anticancer agents |
01/16/2003 | CA2452835A1 Aromatic sulfenates for type i phototherapy |
01/15/2003 | EP1274404A1 Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents |
01/15/2003 | EP0754178B1 Novel functionalized hydrophilic acridinium esters |
01/15/2003 | CN1391469A Npyy5拮抗剂 Npyy5 antagonist |
01/14/2003 | US6506517 Surface modified carbonaceous materials |
01/14/2003 | CA2141494C Mediators suitable for the electrochemical regeneration of nadh, nadph or analogs thereof |
01/08/2003 | EP1095011A4 Novel fluorescent lanthanide chelates |
12/17/2002 | US6495690 By reacting cyclic ketones with aliphatic aldehyde in presence of ammonia in gaseous phase in presence of catalyst |
12/12/2002 | WO2002099428A1 Luciferin hydrazides |
12/12/2002 | WO2002099424A2 Acridone derivatives as labels for fluorescence detection of target materials |
12/12/2002 | WO2002099097A1 Novel compounds for chemiluminescense procedures |
12/12/2002 | CA2754169A1 Acridone derivatives as labels for fluorescence detection of target materials |
12/12/2002 | CA2448824A1 Novel compounds for chemiluminescense procedures |
12/12/2002 | CA2448370A1 Luciferin hydrazides |
12/11/2002 | EP1263733A2 Derivatives of quinoline as alpha-2 antagonists |
12/10/2002 | US6492396 Substituted thioacetamides |
12/05/2002 | US20020183512 Compounds for use in treatment of cancer |
12/05/2002 | US20020183334 For therapy of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, treatment of attention deficit hyperactivity disorder |
12/05/2002 | US20020182581 Treating blood or blood products with compounds which have a mustard, aziridinium or aziridine group and a nucleic acid binding group |
12/05/2002 | US20020179105 Reduced ignition propensity smoking article |
11/27/2002 | EP1259492A1 Substituted piperazine derivatives as mtp inhibitors |
11/26/2002 | CA1341402C Chemiluminescent acridine derivatives and their use in luminescence immunoassays |
11/21/2002 | US20020173651 By reacting cyclic ketones with aliphatic aldehyde in presence of ammonia in gaseous phase in presence of catalyst |
11/20/2002 | EP1257538A2 9-alkylamino-1-nitroacridine derivatives |
11/19/2002 | US6482943 Quinones as disease therapies |
11/13/2002 | EP1255757A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors |
11/12/2002 | US6479504 Antagonism of immunostimulatory CpG-oligonucleotides by 4-aminoquinolines and other weak bases |
11/12/2002 | US6479503 Cycloalkano-indole and -azaindole derivatives |
10/30/2002 | EP1252133A2 Pharmaceutical compounds |
10/23/2002 | EP0778946B1 Novel method and kits for producing light from an acridan compound |
10/16/2002 | EP1249233A1 Npyy5 antagonists |
10/10/2002 | WO2002079191A1 Viologen linked acridine based molecule and process for the preparation thereof |
10/10/2002 | WO2002079166A1 A process for the synthesis of an annulated pyridine base |
10/10/2002 | US20020147209 Cycloalkano-indole and -azaindole derivatives |
10/03/2002 | US20020143034 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
10/02/2002 | EP0679641B1 Sulfonamide and sulfonic ester derivatives each having tricyclic hetero ring |
09/26/2002 | US20020137784 Guanidine derivatives |
09/19/2002 | US20020132821 Novel heteroaryl derivatives and their use as medicaments |
09/19/2002 | US20020130317 Bistable molecular mechanical devices with an appended rotor activated by an electric field for electronic switching, gating and memory applications |
09/19/2002 | US20020130316 A bistable molecule for a crossed-wire device comprising a pair of crossed wires that form a junction where one wire crosses another at an angle other than zero degrees and at least one connector species connecting said pair of crossed |
09/06/2002 | WO2002067704A1 A reduced ignition propensity smoking article |
09/04/2002 | EP0934278B1 Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents |
08/29/2002 | WO2001012584A3 Pharmaceutical compounds |
08/28/2002 | EP1234514A2 A reduced ignition propensity smoking article |
08/28/2002 | EP1234186A1 Stabilizing a luminescent acridinium compound |
08/22/2002 | WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals |
08/15/2002 | US20020111491 Antitumor agents, topoisomerase inhibitors, notoxic |
08/15/2002 | US20020111354 Novel heteroary1 derivatives and their use as medicaments |
08/14/2002 | CN1089086C Luminide and macroluminide class of pharmaceuticals |
08/01/2002 | WO2002059096A1 Processes and synthetic intermediates for preparing n-arylacridancarboxylic acid derivatives |
08/01/2002 | WO2002008190A3 Novel heteroaryl derivatives and use thereof as anti-tumour agents |
08/01/2002 | US20020103214 Novel heteroaryl derivatives and their use as medicaments |
08/01/2002 | US20020102573 Monitoring, detecting, screening and determining pancreatic defects in humans; obtain and determine nucleotide sequence of sample, compare to control, detect mutation, evaluate human for pancreatic defects |
08/01/2002 | US20020102380 Ionic compounds in which the anionic load has been delocalized; ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions including polymerization |
07/30/2002 | CA2056619C Method of inactivation of viral and bacterial blood contaminants |
07/25/2002 | US20020099211 9-alkylamino-1-nitroacridine derivatives |
07/24/2002 | EP1225169A1 Radiation-activated cytotoxin therapy |
07/18/2002 | WO2002055503A1 Bistable tricyclic molecules with an appended rotor activated by an electric field for electronic switching, gating and memory applications |
07/18/2002 | US20020094568 Apparatus for reducing concentration of low molecular weight compounds in biological composition |
07/10/2002 | CN1358178A Pharmaceutical compounds |
07/10/2002 | CN1357542A Fluorescent reagent 2-(N-acridone)-chlorethyl formate |
07/09/2002 | US6417005 Covalently immobilized fluoroionophores as optical ion sensors |
07/04/2002 | WO2002051942A1 Dyeing or printing of manufactured natural polymer and synthetic hydrophobic fibre materials |
07/03/2002 | EP0915837B1 Glyoxylic acid derivatives |
06/25/2002 | US6410732 Processing and synthetic intermediates for preparing N-arylacridancarboxylic acid derivatives |
06/25/2002 | US6410561 Analgesics |
06/25/2002 | US6410219 Dectionn of pathogen deaction of pathogen by complexing |
06/20/2002 | US20020076823 Near infrared chemiluminescent acridinium compounds and uses thereof |
06/19/2002 | CN1354740A Pharmaceutical compounds |
06/12/2002 | EP0907641B1 Fluoroionophores and their use in optical ion sensors |
06/11/2002 | CA2222556C Adduct protection assay |
06/04/2002 | US6399223 Compound for use in organic EL device and organic EL device |
06/04/2002 | CA2029497C 4-acylaminopyridine derivative |
06/04/2002 | CA2020667C 4-acyloxyquinoline derivatives and insecticidal or acaricidal compositions containing same |
05/30/2002 | WO2002043449A1 Luminescent element material and luminescent element comprising the same |
05/28/2002 | US6395367 Electroconductivity |
05/23/2002 | US20020061509 Detecting modulators of parathyroid hormone related peptide expression; obtain cells, transform with expression vectors, culture transformed cells, expose to modulator, monitor cell for adjustment gene expression |
05/14/2002 | US6387547 Compound having naphthacene skeleton for use in organic electroluminescence device; produces light emission of satisfactory luminance, especially at long wavelength; improved light emitting performance lasts for long time |
05/10/2002 | WO2002036568A1 N-type calcium channel antagonists for the treatment of pain |
05/09/2002 | US20020055644 Xanthone analogs for treating infectious diseases and complexation of heme and porphyrins |
05/09/2002 | US20020055635 Cycloalkano-indole and -azaindole derivatives |
05/08/2002 | EP1203091A1 Chemiluminescent substrates of hydrolytic enzymes such as phosphatases |
05/08/2002 | EP1119554A4 Xanthan-ester and acridan substrates for horseradish peroxidase |
05/02/2002 | US20020052512 Diaminopropionic acid derivatives |
05/02/2002 | EP1201650A2 Ionic malonitril derivatives and their uses |
05/02/2002 | DE10051628A1 Mittel zur Inaktivierung von pathogenen Keimen und dessen Verwendung Means for inactivation of pathogenic microorganisms and the use thereof |